| 000 | 02854 a2200541 4500 | ||
|---|---|---|---|
| 001 | 1138020117 | ||
| 005 | 20250317100413.0 | ||
| 008 | 250312042014GB 2 eng | ||
| 020 | _a9781138020115 | ||
| 037 |
_bTaylor & Francis _cGBP 37.99 _fBB |
||
| 040 | _a01 | ||
| 041 | _aeng | ||
| 072 | 7 |
_aJHB _2thema |
|
| 072 | 7 |
_aJBFN _2thema |
|
| 072 | 7 |
_aMBDC _2thema |
|
| 072 | 7 |
_aJBSF11 _2thema |
|
| 072 | 7 |
_aMBS _2thema |
|
| 072 | 7 |
_aMQW _2thema |
|
| 072 | 7 |
_aPDA _2thema |
|
| 072 | 7 |
_aPSF _2thema |
|
| 072 | 7 |
_aPSC _2thema |
|
| 072 | 7 |
_aPSAN _2thema |
|
| 072 | 7 |
_aQD _2thema |
|
| 072 | 7 |
_aJBSF _2thema |
|
| 072 | 7 |
_aJHB _2bic |
|
| 072 | 7 |
_aJFFH _2bic |
|
| 072 | 7 |
_aMBDC _2bic |
|
| 072 | 7 |
_aJFFK _2bic |
|
| 072 | 7 |
_aMBS _2bic |
|
| 072 | 7 |
_aMQW _2bic |
|
| 072 | 7 |
_aPDA _2bic |
|
| 072 | 7 |
_aPSF _2bic |
|
| 072 | 7 |
_aPSC _2bic |
|
| 072 | 7 |
_aPSAN _2bic |
|
| 072 | 7 |
_aHP _2bic |
|
| 072 | 7 |
_aJFSJ _2bic |
|
| 072 | 7 |
_aMED107000 _2bisac |
|
| 072 | 7 |
_aSOC010000 _2bisac |
|
| 072 | 7 |
_aMED050000 _2bisac |
|
| 072 | 7 |
_aSOC026000 _2bisac |
|
| 072 | 7 |
_a174.28 _2bisac |
|
| 100 | 1 | _aJulie Kent | |
| 245 | 1 | 0 |
_aRegenerating Bodies _bTissue and Cell Therapies in the Twenty-First Century |
| 250 | _a1 | ||
| 260 |
_aOxford _bRoutledge _c20140110 |
||
| 300 | _a234 p | ||
| 520 | _bThis exciting book examines how human tissues and cells are being exchanged, commodified and commercialized by new health technologies. Through a discussion of emergent global ‘tissue economies’ the author explores the social dynamics of innovation in the fields of tissue engineering and stem cell science. The book explores how regenerative medicine configures and conceptualizes bodies and argues that the development of regenerative medicine is a feminist issue. In Regenerating Bodies , Kent critically examines the transformative potential of regenerative medicine and whether it represents a paradigm shift from more traditional forms of biomedicine. The book shows that users of these technologies are gendered and women’s bodies are enrolled in the production of them in particular ways. So what is the value of a feminist bioethics for thinking about the ethical issues at stake? Drawing on extensive qualitative field research, Kent examines the issues around donation, procurement, banking and engineering of human tissues, and presents an analysis of the regulatory and policy debates surrounding these practices within Europe and the UK. The book considers the claims that regenerative medicine represents exciting possibilities for treating the diseases of ageing bodies, critically assessing what kind of futures are embodied in tissue and cell based therapies. It will be of interest to a wide range of scholars and students within the social sciences, in health technology studies, bioethics, feminist studies, and gender and health studies. | ||
| 999 |
_c2570 _d2570 |
||